TG Therapeutics (NASDAQ: $TGTX), a commercial-stage biopharmaceutical company, released its Q4 fiscal 2024 results on Monday, March 3, 2025, before markets opened. Here is a […]
Tag: NASDAQ
Nvidia (NASDAQ: NVDA) Releases Q4 Fiscal 2025 Results: Is NVDA Still A Buy After Recent Shakeup In AI Industry?
Nvidia (NASDAQ: $NVDA), a pioneer in GPU-accelerated computing, released its Q4 fiscal 2025 results on Wednesday after market closed. The results come out amid an […]
Intuit (NASDAQ: INTU) Releases Q2 Fiscal 2025 Results: Is INTU Still A Buy In 2025 As It Touches 52-Week Low?
Intuit (NASDAQ: $INTU), a leading company in the income tax preparation products and services industry, released its Q2 fiscal 2025 results on Tuesday, February 25, […]
Aditxt (NASDAQ: ADTX) Subsidiary Pearsanta Prepares For IPO To Drive Launch Of Early Cancer Detection And Diagnosis Test in $31B Market
Aditxt (NASDAQ: $ADTX) announced on Friday, February 21, 2025, that its Subsidiary, Pearsanta, had engaged the services of a lead underwriter as it prepares for […]
Booking Holdings (NASDAQ: BKNG) Soars After Q4 Fiscal 2024 Earnings Beat: Is Now The Time To Add BKNG To Your Portfolio?
Booking Holdings (NASDAQ: $BKNG) is a world leader in online travel, and is behind leading brands like Booking.com, KAYAK, and Priceline. On Thursday, February 20, […]
Tiziana Life Sciences (NASDAQ: TLSA) Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program Amid Strong Momentum: Is TLSA Poised For A Major Breakout?
Tiziana Life Sciences (NASDAQ: $TLSA) is a biotech firm, which is working on comprehensive research efforts to advance novel treatments, and improve patient outcome with […]